Intas
Trending Articles
Related Content
Regulatory
Amarillo partners Intas in interferon-alpha lozenge trials to treat influenza in India
<p>Texan biotech Amarillo Biosciences has agreed to a strategic partnership with Intas Pharmaceuticals of India, whereby Intas will sponsor clinical trials of Amarillo's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay Amarillo a royalty on net sales after marketing approval is obtained in India.</p>